AVIDITY BIOSCIENCES INC (RNA) Stock Analyst Earnings Estimates
NASDAQ:RNA - Nasdaq - US05370A1088 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.22M -1.18% | 9.56M 3.69% | 10.897M 13.99% | 6.879M -36.87% | 20.374M 196.18% | 321.98M 1,480.35% | 799.31M 148.25% | 1.193B 49.25% | 1.867B 56.50% | 2.43B 30.16% | 2.894B 19.09% | |
| EBITDA YoY % growth | -177.52M -51.20% | -233.497M -31.53% | -376.16M -61.10% | -573.532M -52.47% | -699.152M -21.90% | -286.84M 58.97% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -178.91M -51.55% | -235.598M -31.69% | -378.936M -60.84% | -553.138M -45.97% | -626.689M -13.30% | -396.019M 36.81% | -6.444M 98.37% | 364.9M 5,762.21% | 847.76M 132.33% | 1.279B 50.87% | 1.625B 27.05% | |
| Operating Margin | -1,940.46% | -2,464.41% | -3,477.43% | -8,040.96% | -3,075.93% | -122.99% | -0.81% | 30.59% | 45.41% | 52.63% | 56.15% | |
| EPS YoY % growth | -3.33 -17.25% | -2.90 12.91% | -2.89 0.34% | -4.04 -39.95% | -4.52 -11.85% | -3.22 28.89% | 0.09 102.83% | 2.60 2,760.00% | 5.50 111.54% | 7.84 42.61% | 9.64 22.92% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.99 -53.02% | -1.06 -62.98% | -1.13 -40.73% | -1.13 -25.69% |
| Revenue Q2Q % growth | 1.486M -27.33% | 1.484M -36.47% | 1.485M -50.05% | 1.768M 12.40% |
| EBITDA Q2Q % growth | -129.738M -59.58% | -131.033M -36.36% | -133.13M -12.62% | N/A |
| EBIT Q2Q % growth | -131.384M -59.01% | -137.742M -40.36% | -144.069M -19.07% | -147.221M -11.94% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.90 -13.92% | -0.90 | 0.00 | 0.55% |
| Q4 2024 Q2Q % growth | -0.80 -1.27% | -0.80 | 0.00 | -0.04% |
| Q3 2024 Q2Q % growth | -0.65 8.45% | -0.72 | 0.07 | 9.54% |
| Q2 2024 Q2Q % growth | -0.65 1.52% | -0.80 | 0.15 | 18.66% |
| Q1 2024 Q2Q % growth | -0.79 -6.76% | -0.78 | -0.01 | -0.83% |
| Q4 2023 Q2Q % growth | -0.79 10.23% | -0.67 | -0.12 | -18.51% |
| Q3 2023 Q2Q % growth | -0.71 13.41% | -0.78 | 0.07 | 8.47% |
| Q2 2023 Q2Q % growth | -0.66 28.26% | -0.81 | 0.15 | 18.20% |
| Q1 2023 Q2Q % growth | -0.74 -4.23% | -0.86 | 0.12 | 13.76% |
| Q4 2022 Q2Q % growth | -0.88 -7.32% | -0.90 | 0.02 | 1.83% |
| Q3 2022 Q2Q % growth | -0.82 -20.59% | -0.94 | 0.12 | 12.92% |
| Q2 2022 Q2Q % growth | -0.92 -31.43% | -0.76 | -0.16 | -21.11% |
| Q1 2022 Q2Q % growth | -0.71 -10.94% | -0.81 | 0.10 | 11.95% |
| Q4 2021 Q2Q % growth | -0.82 -90.70% | -0.70 | -0.12 | -16.40% |
| Q3 2021 Q2Q % growth | -0.68 -119.35% | -0.68 | 0.00 | 0.62% |
| Q2 2021 Q2Q % growth | -0.70 43.09% | -0.72 | 0.02 | 2.73% |
| Q1 2021 Q2Q % growth | -0.64 | -0.56 | -0.08 | -13.83% |
| Q4 2020 Q2Q % growth | -0.43 | -0.35 | -0.08 | -24.03% |
| Q3 2020 Q2Q % growth | -0.31 | -0.37 | 0.06 | 16.08% |
| Q2 2020 Q2Q % growth | -1.23 | -0.24 | -0.99 | -407.43% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.573M -55.60% | 1.919M | -346K | -18.03% |
| Q4 2024 Q2Q % growth | 2.973M 35.57% | 1.54M | 1.433M | 93.05% |
| Q3 2024 Q2Q % growth | 2.336M -17.10% | 4.31M | -1.974M | -45.80% |
| Q2 2024 Q2Q % growth | 2.045M -11.70% | 2.663M | -618K | -23.21% |
| Q1 2024 Q2Q % growth | 3.543M 58.67% | 2.587M | 956K | 36.95% |
| Q4 2023 Q2Q % growth | 2.193M -20.83% | 12.333M | -10.14M | -82.22% |
| Q3 2023 Q2Q % growth | 2.818M 13.63% | 1.863M | 955K | 51.26% |
| Q2 2023 Q2Q % growth | 2.316M 6.24% | 2.166M | 150K | 6.93% |
| Q1 2023 Q2Q % growth | 2.233M 24.06% | 2.065M | 168K | 8.14% |
| Q4 2022 Q2Q % growth | 2.77M 49.73% | 2.338M | 432K | 18.48% |
| Q3 2022 Q2Q % growth | 2.48M 14.81% | 2.399M | 81K | 3.38% |
| Q2 2022 Q2Q % growth | 2.18M -16.48% | 2.083M | 97K | 4.66% |
| Q1 2022 Q2Q % growth | 1.8M -33.33% | 1.919M | -119K | -6.20% |
| Q4 2021 Q2Q % growth | 1.85M -13.55% | 2.197M | -347K | -15.79% |
| Q3 2021 Q2Q % growth | 2.16M 23.43% | 2.146M | 14K | 0.65% |
| Q2 2021 Q2Q % growth | 2.61M 69.48% | 1.957M | 653K | 33.37% |
| Q1 2021 Q2Q % growth | 2.7M 98.53% | 1.01M | 1.69M | 167.33% |
| Q4 2020 Q2Q % growth | 2.14M | 847.138K | 1.293M | 152.62% |
| Q3 2020 Q2Q % growth | 1.75M | 573.175K | 1.177M | 205.32% |
| Q2 2020 Q2Q % growth | 1.54M 600.00% | 370.337K | 1.17M | 315.84% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.17% | -5.55% | 0.73% | -2.77% |
| Revenue | 0.61% | -27.33% | 8.33% | 7.12% |